ArticleClinical nephrology2025

Efficacy and safety of add-on treatment with finerenone in patients with diabetic kidney disease already treated with SGLT-2 inhibitors.

Manja Antonič et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.